Charles River Laboratories International Inc at Barclays Global Healthcare Conference Transcript
Well, thank you, and good morning. I'm Jack Meehan, the Barclay's licensed tools, diagnostics analyst. I'm pleased to be joined by Jim Foster, the Chairman and CEO of Charles River Labs. Maybe to kick off, we're going to just get some audience response questions. If you see the Blackberrys in front of you. First question, how do you view Charles River's organic growth profile over the next 3 years? We'll get the answer later from Jim.
(Voting)
We did get a strategy update over the summer, so we'll compare and contrast. Mostly in the mid-single-digits blend around that.
Second question, do you expect organic growth to accelerate from current levels and when? I would note some of the recent growth has been pretty robust. But let's see what the audience thinks.
(Voting)
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
